SPX (NYSE:SPXC) reported quarterly earnings of $0.71 per share which beat the analyst consensus estimate of $0.61 by 16.39 percent. This is a 44.9 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $354.00 million which beat the analyst consensus estimate of $337.81 million by 4.79 percent. This is a 19.31 percent increase over sales of $296.70 million the same period last year.
ABVC BioPharma Introduces Dietary Supplement Based On Maitake Mushroom, Enters Into $3M Distribution Agreement
ABVC Biopharma, Inc. (NASDAQ:ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced that BioKey, a wholly-owned subsidiary of
